Science Translational Medicine Journal Issues Research Articles in Jan. 24, 2024 Edition
January 25, 2024
January 25, 2024
NEW YORK, Jan. 25 -- Science Translational Medicine, a peer-reviewed journal from the American Association for the Advancement of Science that focuses on research in the translational medicine community, published research articles on the following topics in its Jan. 24, 2024, edition (Vol. 16, Issue 731):
Research Articles:
* The CSF-1R inhibitor pexidartinib affects FLT3-dependent DC differentiation and may antagonize durvalumab effect in patients with advanced cance . . .
Research Articles:
* The CSF-1R inhibitor pexidartinib affects FLT3-dependent DC differentiation and may antagonize durvalumab effect in patients with advanced cance . . .